跳至主要内容
临床试验/NL-OMON50522
NL-OMON50522已完成不适用

Establishing elevated lipoprotein(a) as a target in calcific aortic valve disease - CALCIFY

Academisch Medisch Centrum0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • - Adult patients, aged 45-80 years old
  • - Mild to moderate aortic valve stenosis: on echocardiography, aortic valve maximum velocity is >2.0 m/sec

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • - Severe aortic valve stenosis
  • - History of radiotherapy of the thorax
  • - History of rheumatic fever
  • - Renal insufficiency, defined as eGFR < 30 ml/min
  • - Hyperparathyroidism
  • - Paget*s disease of the bone
  • - Any other treatment or clininically relevant condition that could interfere with the conduct or interpretation of the study in the opinion of the investigator
  • - Standard contra-indications to PET/CT

研究者

相似试验